Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 9, 1996, Pages 24-34

  Peterson, Bradley S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; CLOZAPINE; DOPAMINE; HALOPERIDOL; NORADRENALIN; PIMOZIDE; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADAPTIVE BEHAVIOR; AFFECT; BASAL GANGLION; CONFERENCE PAPER; COPING BEHAVIOR; DISEASE COURSE; DOPAMINERGIC SYSTEM; GILLES DE LA TOURETTE SYNDROME; HUMAN RELATION; MEDICAL DECISION MAKING; MINIMAL BRAIN DYSFUNCTION; NORADRENERGIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; PATHOPHYSIOLOGY; PERSONALITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SELF ESTEEM; SOCIALIZATION; STRESS;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; CHILD; CLOZAPINE; DISEASE PROGRESSION; DISEASES IN TWINS; DOPAMINE; HALOPERIDOL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; PIMOZIDE; RISPERIDONE; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 0029835948     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. Apter A, Pauls DL, Bleich A, et al. An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 1993;50:7 34-738
2. Burd L, Kerbeshian J, Wikenheiser M, et al. Prevalence of Gilles de la Tourette's syndrome in North Dakota adults. Am J Psychiatry 1986;143: 787-788
3. Comings DE, Himes JA, Comings BG. An epidemiologic study of Tourette's syndrome in a single school district. J Clin Psychiatry 1990; 51:463-469
4. Shapiro AK, Shapiro ES, Young JG, et al. Signs, symptoms, and clinical course. In: Shapiro AK, Shapiro ES, Young JG, et al, eds. Gilles de la Tourette Syndrome. New York, NY: Raven Press; 1988:127-193
5. Burd L, Kerbeshian J. Onset of Gilles de la Tourette's syndrome before 1 year of age. Am J Psychiatry 1987;144:1066-1067
6. Bruun RD. The natural history of Tourette's syndrome. In: Cohen DJ, Bruun RD, Leckman JF, eds. Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley & Sons; 1988:21-39
7. Berkson JB. Limitations of the application of fourfold table analysis to hospital data. Biometrics 1946;2:47-51
8. Randolph C, Hyde TM, Gold JM, et al. Tourette's syndrome in monozygotic twins: relationship of tic severity to neuropsychological function. Arch Neurol 1993;50:725-728
9. Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980;37:1343-1347
10. Kurlan R, Lichter D, Hewitt D. Sensory tics in Tourette's syndrome. Neurology 1989;39:731-734
11. Lang A. Patient perception of tics and other movement disorders. Neurology 1991;41:223-228
12. Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993;150:98-102
13. George MS, Trimble MR, Ring HA, et al. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 1993;150:93-97
14. Leckman JF, Walker DE, Goodman WK, et al. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994;151:675-680
15. Carter AS, Pauls DL, Leckman JF, et al. A prospective longitudinal study of Gilles de la Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1994;33:377-385
16. Stokes A, Bawden HN, Camfield PR, et al. Peer problems in Tourette's disorder. Pediatrics 1991;87:936-942
17. Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: a follow-up study. Ann Neurol 1987;22:383-385
18. Nee LE. Tourette syndrome: clinical and family studies. In: Friedhoff AJ, Chase TN, eds. Gilles de la Tourette Syndrome. New York, NY: Raven Press; 1982:291-295
19. Goetz CG, Tanner CM, Stebbins GT, et al. Adult tics in Gilles de la Tourette's syndrome: description and risk factors. Neurology 1992;42: 784-788
20. Park S, Como PG, Cui L, et al. The early course of the Tourette's syndrome clinical spectrum. Neurology 1993;43:1712-1715
21. Hyde TM, Aaronson BA, Randolph C, et al. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992;42:652-658
22. Price RA, Kidd KK, Cohen DJ, et al. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985;42:815-820
23. Walkup JT, Leckman JF, Price RA, et al. The relationship between obsessive-compulsive disorder and Tourette's syndrome: a twin study. Psychopharmacol Bull 1988;24:375-379
24. Pauls DL, Raymond CL, Stevenson JM, et al. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991;48:154-163
25. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 1986;315:993-997
26. Pakstis AJ, Heutink P, Pauls DL, et al. Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet 1991;48:281-294
27. Pauls DL, Towbin KE, Leckman JF, et al. Gilles de la Tourette's syndrome and obsessive-compulsive disorder: evidence supporting a genetic relationship. Arch Gen Psychiatry 1986;43:1180-1182
28. Leckman JF, Price RA, Walkup JT, et al. Nongenetic factors in Gilles de la Tourette's syndrome [letter]. Arch Gen Psychiatry 1987;44:100
29. Leckman JF, Dolnansky ES, Hardin MT, et al. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 1990;29:220-226
30. Mesulam MM. Cocaine and Tourette's syndrome [letter]. N Engl J Med 1986;315:398
31. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993;92:39-43
32. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies: tics and obsessive compulsive symptoms [abstract]. J Dev Behav Pediatr 1993;14:281-282
33. Santangelo SL, Pauls DL, Goldstein JM, et al. Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder? J Am Acad Child Adolesc Psychiatry 1994;33:795-804
34. Baldwin M, Frost LL, Wood CD. Investigation of the primate amygdala: movements of the face and jaws. Neurology 1954;4:596-598
35. McLean P, Delgado J. Electrical and chemical stimulation of frontotemporal portion of limbic system in the waking animal. Electroencephalogr Clin Neurophysiol 1953;5:91-100
36. Kelley AE, Lang CG, Gauthier AM. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berl) 1988;95:556-559
37. Leckman JF, de Lotbiniere AJ, Marek K, et al. Severe disturbances in speech, swallowing, and gait following stereotactic infrathalamic lesions in Gilles de la Tourette's syndrome. Neurology 1993;43:890-894
38. Peterson B, Riddle MA, Cohen DJ, et al. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 1993;43:941-949
39. Singer HS, Reiss AL, Brown JE, et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993;43: 950-956
40. Peterson BS, Leckman JF, Duncan JS, et al. Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res 1994;55:85-99
41. Peterson BS, Gore JC, Riddle MA, et al. Abnormal magnetic resonance imaging T2 relaxation time asymmetries in Tourette's syndrome. Psychiatry Res 1994;55:205-221
42. Yazgan MY, Peterson BS, Wexler BE, et al. Behavioral laterality in individuals with Gilles de la Tourette's syndrome and basal ganglia alterations: a preliminary report. Biol Psychiatry. In press
43. Fleming B, Anderson R, Rhees R, et al. Effects of prenatal stress on sexually domorphic 21 in the cerebral cortex of the rat. Brain Res Bull 1986; 16:395-398
44. Fride E, Soreq H, Weinstock M. Are the effects of gestational stress on motor development and cerebellar cholinesterase activity mediated prenatally? Int J Devel Neurosci 1986;4:407-413
45. Fride E, Dan Y, Feldon J, et al. Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats. Physiol Behav 1986;37: 681-687
46. Takahashi LK, Turner JG, Kalin NH. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 1992;574:131-137
47. Chappell P, Riddle M, Anderson G, et al. Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biol Psychiatry 1994;36:35-43
48. Singer HS, Hahn IH, Moran TH. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991;30:558-562
49. Anderson GM, Pollak ES, Chatterjee D, et al. Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv Neurol 1992;58:123-133
50. 123I]Beta-CIT SPECT imaging demonstrates increased striatal dopamine transporter binding in Tourette's syndrome. Am J Psychiatry. In press
51. Brooks DJ, Turjanski N, Sawle GV, et al. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Adv Neurol 1992;58:227-231
52. Singer HS, Wong DF, Brown JE, et al. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome. Adv Neurol 1992;58:233-239
53. George MS, Robertson MM, Costa DC, et al. Dopamine receptor availability in Tourette's syndrome. Psychiatry Res 1994;55:193-203
54. Butler IJ, Koslow SH, Seifert W Jr, et al. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979;6:37-39
55. Cohen DJ, Shaywitz BA, Young JG, et al. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry 1979;18:320-341
56. Leckman JF, Goodman WK, Anderson GM, et al. Cerebrospinal fluid biogenie amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995;12:73-86
57. Jankovic J, Glaze DG, Frost J Jr. Effect of letrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology 1984;34:688-692
58. Sweet RD, Bruun R, Shapiro E, et al. Presynaptic catecholamine antagonists as treatment for Tourette syndrome: effects of α-methyl-p-tyrosine and tetrabenazine. Arch Gen Psychiatry 1976;31:857-861
59. Golden GS. Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 1974;16:76-78
60. Lowe TL, Cohen DJ, Detlor J, et al. Stimulant medications precipitate Tourette's syndrome. JAMA 1982;247:1168-1169
61. Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991;48:324-328
62. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995;95: 74-81
63. Harrington R, Fudge H, Rutter M, et al. Adult outcomes of childhood and adolescent depression, I: psychiatric status. Arch Gen Psychiatry 1990;47: 465-473
64. Shapiro AK, Shapiro ES, Young JG, et al. History of Tourette and tic disorders. In: Shapiro AK, Shapiro ES, Young JG. et al, eds. Gilles de la Tourette Syndrome. New York, NY: Raven Press; 1988:1-27
65. Cohen DJ, Detlor J, Young JG, et al. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980;37:1350-1357
66. Riddle MA, Anderson GM, McIntosh S, et al. Cerebrospinal fluid monoamine precursor and metabolite levels in children treated for leukemia: age and sex effects and individual variability. Biol Psychiatry 1986;21: 69-83
67. Shaywitz BA, Cohen DJ, Leckman JF, et al. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders. Dev Med Child Neurol 1980;22:748-754
68. Seeman P, Bzowej NH, Guan HC, et al. Human brain dopamine receptors in children and aging adults. Synapse 1987;1:399-404
69. Leckman JF, Ort S, Caruso KA, et al. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine: behavioral, cardiovascular, and neurochemical effects. Arch Gen Psychiatry 1986;43:1168-1176
70. Mikkelsen EJ, Detlor J, Cohen DJ. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. Am J Psychiatry 1981;138:1572-1576
71. Ross MS, Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 1978; 135:585-587
72. Shapiro E, Shapiro AK, Fulop G, et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989;46:722-730
73. Regeur L, Pakkenberg B, Fog R, et al. Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 1986;49:791-795
74. Lombroso PJ, Scahill L, King RA, et al. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J Am Acad Child Adolesc Psychiatry. In press
75. Bruun RD, Budman CL. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996;57:29-31
76. van der Linden C, Briggeman R, van Woerkom TCAM. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone. Movement Disorders 1994;9: 687-688
77. Caine ED, Polinsky RJ, Kartzinel R, el al. The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 1979;136: 317-320
78. McDougle CJ, Barr LC, Goodman WK, et al. Limited efficacy of clozapine monotherapy in refractory obsessive compulsive disorder. Am J Psychiatry. In press
79. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 1994;55(3, suppl):24-31
80. Hunt RD, Arnsk AFT, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:50-54
81. Chappell PB, Riddle MA, Scahill L, et al. Guanfacine treatment of comorbid attention deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry. In press
82. Spencer T, Biederman J, Wilens T. Tricyclic antidepressant treatment of children with ADHD and tic disorders. J Am Acad Child Adolesc Psychiatry 1994;33:1203-1204